Long-term safety and efficacy of subcutaneous abatacept in patients with rheumatoid arthritis: 5-year results from a phase IIIb trial
Genovese MC et al. J Rheumatol 2018. doi: 10.3899/jrheum.170344
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.